argenx
Julie Deckers is a Scientist in Discovery at argenx since May 2023. Prior to this role, Julie served as a Postdoctoral Researcher at VIB from July 2017 to May 2023 and as a Predoctoral Researcher at UGent - VIB from August 2011 to July 2017. Julie holds a Master's degree in Biomedical Sciences, General, obtained from KU Leuven between 2006 and 2011.
This person is not in any teams
This person is not in any offices
argenx
32 followers
Argenx discovers, designs and develops innovative antibody therapeutics for its own pipeline of treatments for cancer and autoimmune diseases and for its partners. Harnessing our technology and know-how, we aim to meet the needs of patients by engineer...